BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21199428)

  • 1. Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma.
    Hayden AJ; Martin JM; Kneebone AB; Lehman M; Wiltshire KL; Skala M; Christie D; Vial P; McDowall R; Tai KH;
    J Med Imaging Radiat Oncol; 2010 Dec; 54(6):513-25. PubMed ID: 21199428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer.
    Skala M; Berry M; Duchesne G; Gogna K; Tai KH; Turner S; Kneebone A; Rolfo A; Haworth A
    Australas Radiol; 2004 Dec; 48(4):493-501. PubMed ID: 15601330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.
    Tai KH; Duchesne G; Turner S; Kneebone A; See A; Gogna K; Berry M
    Australas Radiol; 2004 Dec; 48(4):502-8. PubMed ID: 15601331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder.
    Hindson BR; Turner SL; Millar JL; Foroudi F; Gogna NK; Skala M; Kneebone A; Christie DR; Lehman M; Wiltshire KL; Tai KH;
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):18-30. PubMed ID: 22339742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group.
    Sidhom MA; Kneebone AB; Lehman M; Wiltshire KL; Millar JL; Mukherjee RK; Shakespeare TP; Tai KH
    Radiother Oncol; 2008 Jul; 88(1):10-9. PubMed ID: 18514340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.
    Moran BJ; DeRose P; Hsu IC; Abdel-Wahab M; Arterbery VE; Ciezki JP; Frank SJ; Mohler JL; Rosenthal SA; Rossi CJ; Yamada Y; Merrick GS
    Am J Clin Oncol; 2011 Dec; 34(6):636-47. PubMed ID: 22101389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer].
    Latorzeff I; Mazurier J; Boutry C; Dudouet P; Richaud P; de Crevoisier R
    Cancer Radiother; 2010 Oct; 14(6-7):479-87. PubMed ID: 20797889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer.
    Jereczek-Fossa BA; Orecchia R
    Radiother Oncol; 2007 Aug; 84(2):197-215. PubMed ID: 17532494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in Japan.
    Nakamura K; Akimoto T; Mizowaki T; Hatano K; Kodaira T; Nakamura N; Kozuka T; Shikama N; Kagami Y
    Jpn J Clin Oncol; 2012 Jan; 42(1):53-7. PubMed ID: 22131339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological advances in radiotherapy for the treatment of localised prostate cancer.
    Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
    Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensity Modulated Radiation Therapy (IMRT)].
    Maebayashi K; Nasu S; Seki K; Kiyoduka M; Hashimoto Y; Mitsuhashi N
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):436-43. PubMed ID: 16612150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in prostate cancer radiotherapy: consensus development.
    Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
    Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
    Teh BS; Paulino A; Butler EB
    Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current external beam radiation therapy quality assurance guidance: does it meet the challenges of emerging image-guided technologies?
    Palta JR; Liu C; Li JG
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S13-7. PubMed ID: 18406911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
    Yu HH; Song DY; Tsai YY; Thompson T; Frassica DA; DeWeese TL
    Urology; 2007 Jul; 70(1):111-6. PubMed ID: 17656219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
    Zelefsky MJ; Marion C; Fuks Z; Leibel SA
    J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.